The exosome revolution: Bridging early detection and personalized treatment

Exosomes, small extracellular vesicles, have garnered attention for their significant role in diagnostics and personalized medicine. Released by cells, they contain biomolecules like proteins, lipids, and nucleic acids that mirror the health or disease status of the source cells. This makes exosomes valuable for detecting diseases early, including cancer, neurodegenerative disorders, and cardiovascular conditions. Advances in the methods used to isolate and analyze exosomes have highlighted their potential as non-invasive diagnostic tools, allowing for more accurate disease detection and monitoring. In the realm of personalized treatment, exosomes offer promising potential as delivery vehicles for targeted therapies. Their natural ability to cross biological barriers and home in on specific tissues positions them as ideal candidates for delivering treatments, such as RNA, proteins, or small molecules, in precision medicine approaches. This review delves into the evolving role of exosomes in both early diagnosis and tailored therapeutic interventions, while also addressing the existing challenges in their application and translation to clinical practice. By uniting the fields of diagnostics and therapeutics, exosomes are set to play a crucial role in the future of healthcare.